Close
FINDING CURES TOGETHER<sup>SM</sup>

New Therapeutic Approved by FDA to Treat Breast Cancer

This blog post covers the recent FDA approval of the molecularly targeted therapeutic ribociclib (Kisqali) for use in combination with any aromatase inhibitor for initial treatment of postmenopausal women with a specific subtype of breast cancer.

AACR in the News

Bad Diet in Teen Years Could Raise Later Breast Cancer Risk

NBC News.com reports on this study published in the AACR journal Cancer Research.